Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from ...

Polyrizon (PLRZ) announced “positive” results from a new in-vitro pre-clinical study evaluating the allergen-blocking performance of its PL-14 ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Effective Sjögren’s management demands a strict separation between symptomatic relief for sicca and immunosuppression for ...

Evidence from multiple model systems supports a shift away from heme transport and toward metabolic dysfunction and oxidative stress as key drivers of TANGO2 deficiency.

Investing.com -- Polyrizon Ltd (NASDAQ:PLRZ) stock gained 2.8% on Monday after the pre-clinical-stage biotechnology company announced positive results from an in-vitro study of its PL-14 Allergy ...

Fiber that naturally occurs in whole foods provides other nutrients like vitamins, minerals, plant compounds, and water, Petitpain said. However, "fake" or isolated fibers are extracted from plants or ...

Robin has worked as a credit cards, editor and spokesperson for over a decade. Prior to Forbes Advisor, she also covered credit cards and related content for other national web publications including ...